That is not a marginal difference
Indicator #5 The 10X Financial Multiplier Effect of GLP-1 Products (FIGURE 5) GLP-1 Revenue Vs
Within dietary supplements, its share remains under 1%, while in functional foods and beverages, it accounts for less than 0.5%
The US domestic peptide market features dozens of vendors claiming "pharmaceutical grade" quality with third-party testing, making differentiation challenging when most provide similar COA documentation, comparable pricing structures, and nearly identical product catalogs featuring BPC-157 , TB-500 , semaglutide , and growth hormone peptides
In fact, for most of us, making adjustments to increase GLP-1 naturallyeven if those changes are smallwill help us get to where we need to be
UK NHS, Jan 3, 2024